Article
Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer.
Molecular cancer therapeutics - 1 Apr 2015
Karginova Olga, Siegel Marni B, Van Swearingen Amanda E D, Deal Allison M, Adamo Barbara, Sambade Maria J, Bazyar Soha, Nikolaishvili-Feinberg Nana, Bash Ryan, O'Neal Sara, Sandison Katie, Parker Joel S, Santos Charlene, Darr David, Zamboni William, Lee Yueh Z, Miller C Ryan, Anders Carey K
Abstract excerpt
Patients with breast cancer brain metastases have extremely limited survival and no approved systemic therapeutics. Triple-negative breast cancer (TNBC) commonly metastasizes to the brain and predicts poor prognosis. TNBC frequently harbors BRCA mutations translating to platinum sensitivity potentially augmented by additional suppression of DNA repair mechanisms through PARP inhibition. We evaluated brain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
